Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)
Clinical trial NCT02797821 · COMPLETED
Trial details
- NCT number
- NCT02797821
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-06
- Primary completion
- 2017-06-21
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.